May, 27 2026, 10 Comments
Discover the real cost difference between brand biologics and biosimilars. Learn how biosimilars offer significant savings, the challenges facing adoption, and what this means for your healthcare costs in 2026.
Read More
Apr, 1 2026, 15 Comments
Understanding how biosimilar safety is tracked through adverse event monitoring systems, including differences from generic drugs and current global regulatory frameworks.
Read More
Feb, 2 2026, 10 Comments
Generic drugs are set to dominate global healthcare as patent expirations surge, driving down costs and expanding access. Forecasts show the market could hit $700B+ by 2030, led by biosimilars, Asia-Pacific growth, and complex drug manufacturing advances.
Read More